This inventor holds 4 USPTO granted patents and 5 published patent applications. Top assignee: Nanomimetics, Inc.. Active years: 2004-2015.
Location History:
- Cleveland Heights, OH (US) (2004 - 2007)
- Dublin, OH (US) (2012 - 2015)
Company Filing History:
Years Active: 2004-2015
Title: Mark A Ruegsegger: Innovator in Surfactant Polymers
Introduction
Mark A Ruegsegger is a notable inventor based in Dublin, OH (US). He has made significant contributions to the field of biomaterials through his innovative work on surfactant polymers. With a total of 4 patents, Ruegsegger's inventions focus on enhancing the surface properties of medical devices.
Latest Patents
Ruegsegger's latest patents include methods of making and using surfactant polymers that are designed to change the surface properties of biomaterials. These surfactant polymers consist of a polymeric backbone made up of repeating monomeric units that have functional groups for coupling with side chains. The polymers feature a variety of hydrophobic side chains linked to the backbone via these functional groups, as well as hydrophilic side chains. Medical devices coated with these surfactant polymers are also part of his innovations. The surfactant polymers are particularly useful in decreasing the thrombogenic properties, encapsulation, and bacterial colonization of medical devices.
Career Highlights
Mark A Ruegsegger is currently associated with Nanomimetics, Inc., where he continues to develop his groundbreaking work in surfactant polymers. His expertise in this area has positioned him as a key figure in the advancement of medical device technology.
Collaborations
Ruegsegger has collaborated with notable colleagues such as Roger Marchant and Tianhong Zhang. Their combined efforts contribute to the innovative research and development in the field of biomaterials.
Conclusion
Mark A Ruegsegger's work in surfactant polymers represents a significant advancement in medical technology. His contributions are paving the way for improved medical devices that enhance patient safety and efficacy.